Biogen to Report First Quarter 2018 Financial Results on April 24, 2018
March 28 2018 - 4:01PM
Business Wire
Biogen Inc. (NASDAQ:BIIB) today announced it will report first
quarter 2018 financial results on Tuesday, April 24, 2018, before
the financial markets open.
Following the release of the financials, the Company will host a
live webcast with Biogen management from 8:30-9:30 am ET. To access
the live webcast, please go to the investors section of Biogen’s
website. Following the live webcast, an archived version of the
call will be available on the website.
About Biogen
At Biogen, our mission is clear: we are pioneers in
neuroscience. Biogen discovers, develops, and delivers worldwide
innovative therapies for people living with serious neurological
and neurodegenerative diseases. Founded in 1978 as one of the
world’s first global biotechnology companies by Charles Weissman,
Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter
Gilbert and Phillip Sharp, today Biogen has the leading portfolio
of medicines to treat multiple sclerosis; has introduced the first
and only approved treatment for spinal muscular atrophy; and is
focused on advancing neuroscience research programs in Alzheimer’s
disease and dementia, multiple sclerosis and neuroimmunology,
movement disorders, neuromuscular disorders, pain, ophthalmology,
neuropsychiatry, and acute neurology. Biogen also manufactures and
commercializes biosimilars of advanced biologics. We routinely post
information that may be important to investors on our website at
www.biogen.com. To learn more, please visit www.biogen.com and
follow us on social media – Twitter, LinkedIn, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180328006032/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2024 to May 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From May 2023 to May 2024